
Precision biologics: the key to reducing antibiotic use in livestock?
Canada’s NovoBind, which is developing a precision biologics platform to protect livestock against pathogenic bacteria, viruses, and parasites, has closed a Series A round of funding.
Sponsored
Here’s where AI could make the biggest impact in the agrifoodtech sector